Literature DB >> 16618704

FRET analysis of in vivo dimerization by RNA-editing enzymes.

Kaari A Chilibeck1, Tao Wu, Chao Liang, Matthew J Schellenberg, Emily M Gesner, Jeffrey M Lynch, Andrew M MacMillan.   

Abstract

Members of the ADAR (adenosine deaminase that acts on RNA) enzyme family catalyze the hydrolytic deamination of adenosine to inosine within double-stranded RNAs, a poorly understood process that is critical to mammalian development. We have performed fluorescence resonance energy transfer experiments in mammalian cells transfected with fluorophore-bearing ADAR1 and ADAR2 fusion proteins to investigate the relationship between these proteins. These studies conclusively demonstrate the homodimerization of ADAR1 and ADAR2 and also show that ADAR1 and ADAR2 form heterodimers in human cells. RNase treatment of cells expressing these fusion proteins changes their localization but does not affect dimerization. Taken together these results suggest that homo- and heterodimerization are important for the activity of ADAR family members in vivo and that these associations are RNA independent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618704     DOI: 10.1074/jbc.M511831200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

2.  Extra double-stranded RNA binding domain (dsRBD) in a squid RNA editing enzyme confers resistance to high salt environment.

Authors:  Juan Pablo Palavicini; Rodrigo A Correa-Rojas; Joshua J C Rosenthal
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

Review 3.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 4.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

Review 5.  ADAR proteins: double-stranded RNA and Z-DNA binding domains.

Authors:  Pierre Barraud; Frédéric H-T Allain
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

Authors:  Leng Han; Lixia Diao; Shuangxing Yu; Xiaoyan Xu; Jie Li; Rui Zhang; Yang Yang; Henrica M J Werner; A Karina Eterovic; Yuan Yuan; Jun Li; Nikitha Nair; Rosalba Minelli; Yiu Huen Tsang; Lydia W T Cheung; Kang Jin Jeong; Jason Roszik; Zhenlin Ju; Scott E Woodman; Yiling Lu; Kenneth L Scott; Jin Billy Li; Gordon B Mills; Han Liang
Journal:  Cancer Cell       Date:  2015-10-01       Impact factor: 31.743

7.  Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.

Authors:  Dama Laxminarayana; Kenneth S O'Rourke; Stefan Maas; Irene Olorenshaw
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

8.  RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.

Authors:  Aparna Anantharaman; Omid Gholamalamdari; Abid Khan; Je-Hyun Yoon; Michael F Jantsch; Jochen C Hartner; Myriam Gorospe; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  FEBS Lett       Date:  2017-08-30       Impact factor: 4.124

9.  Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28.

Authors:  Dama Laxminarayana; Islam U Khan; Kenneth S O'Rourke; Banabihari Giri
Journal:  Immunology       Date:  2007-09-25       Impact factor: 7.397

10.  Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.

Authors:  Minati Singh
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.